Prashant Dattatraya Bhave
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Prashant Dattatraya Bhave has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
- Matthew J. Singleton
Department of Cardiovascular Medicine, WellSpan Health, York, Pennsylvania
9 shared publications - Elsayed Z. Soliman
Epidemiological Cardiology Research Center, Department of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
7 shared publications George Bodziock
Wake Forest University School of Medicine
5 shared publicationsNatalie Bradford
Department of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
5 shared publicationsJonathan Brock
Department of Cardiology Wake Forest School of Medicine Winston Salem North Carolina USA
4 shared publicationsMatthew J. Singleton
Wellspan Health, York, USA
4 shared publications
Latest Publications
- Open Access
Bidirectional relationship between Sleep Disturbance and Atrial Fibrillation: a SPRINT-based analysis
Background: Sleep disturbance has been associated with atrial fibrillation (AF), but prior studies have largely relied on sleep assessed at a single time point or examined specific sleep disorders. Whether changes in sleep disturbance over time predict AF and, conversely, whether AF predicts subsequent sleep disturbance within the same population is not well established. Methods: We conducted a secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), which enrolled adults with hypertension and increased cardiovascular risk without diabetes. Two prospective analytic cohorts were constructed to examine each direction of the association: 7,232 participants without baseline AF for the analysis of sleep disturbance and incident AF, and 6,079 participants without clinically significant sleep disturbance at baseline for the reciprocal analysis. Sleep disturbance was assessed repeatedly using a 0–3 patient-reported symptom score, with clinically significant sleep disturbance defined as a score ≥2. AF was ascertained from protocol 12-lead ECGs. Time-dependent Cox models evaluated time-updated sleep disturbance in relation to incident AF and time-updated AF in relation to incident clinically significant sleep disturbance, with adjustment for demographic, lifestyle, and cardiovascular risk factors. Results: During a median follow-up of 3.3 years, 189 incident AF events occurred. Time-updated clinically significant sleep disturbance was associated with a 78% higher adjusted risk of incident AF (HR, 1.78; 95% CI, 1.27–2.51). Each 1-point increase in the time-updated sleep score was associated with a 26% higher risk of AF (HR, 1.26; 95% CI, 1.09–1.46). Compared with a sleep score of 0, the adjusted HRs were 1.20 (95% CI, 0.85–1.70), 2.05 (95% CI, 1.33–3.15), and 1.72 (95% CI, 1.03–2.88) for scores of 1, 2, and 3, respectively. In the reciprocal analysis, 1,422 incident clinically significant sleep-disturbance events occurred during a median follow-up of 3.2 years. Time-updated AF was associated with a 59% higher adjusted risk of incident clinically significant sleep disturbance (HR, 1.59; 95% CI, 1.16–2.16). Associations in both directions were consistent across prespecified subgroups, with no significant effect modification. Conclusion: In adults with hypertension, sleep disturbance and AF were prospectively and reciprocally associated when evaluated longitudinally. These findings support a bidirectional relationship between sleep disturbance and AF and highlight the potential clinical relevance of assessing sleep health in patients with or at risk for AF.
Open AccessBidirectional relationship between Sleep Disturbance and Atrial Fibrillation: a SPRINT-based analysis
Background: Sleep disturbance has been associated with atrial fibrillation (AF), but prior studies have largely relied on sleep assessed at a single time point or examined specific sleep disorders. Whether changes in sleep disturbance over time predict AF and, conversely, whether AF predicts subsequent sleep disturbance within the same population is not well established. Methods: We conducted a secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), which enrolled adults with hypertension and increased cardiovascular risk without diabetes. Two prospective analytic cohorts were constructed to examine each direction of the association: 7,232 participants without baseline AF for the analysis of sleep disturbance and incident AF, and 6,079 participants without clinically significant sleep disturbance at baseline for the reciprocal analysis. Sleep disturbance was assessed repeatedly using a 0–3 patient-reported symptom score, with clinically significant sleep disturbance defined as a score ≥2. AF was ascertained from protocol 12-lead ECGs. Time-dependent Cox models evaluated time-updated sleep disturbance in relation to incident AF and time-updated AF in relation to incident clinically significant sleep disturbance, with adjustment for demographic, lifestyle, and cardiovascular risk factors. Results: During a median follow-up of 3.3 years, 189 incident AF events occurred. Time-updated clinically significant sleep disturbance was associated with a 78% higher adjusted risk of incident AF (HR, 1.78; 95% CI, 1.27–2.51). Each 1-point increase in the time-updated sleep score was associated with a 26% higher risk of AF (HR, 1.26; 95% CI, 1.09–1.46). Compared with a sleep score of 0, the adjusted HRs were 1.20 (95% CI, 0.85–1.70), 2.05 (95% CI, 1.33–3.15), and 1.72 (95% CI, 1.03–2.88) for scores of 1, 2, and 3, respectively. In the reciprocal analysis, 1,422 incident clinically significant sleep-disturbance events occurred during a median follow-up of 3.2 years. Time-updated AF was associated with a 59% higher adjusted risk of incident clinically significant sleep disturbance (HR, 1.59; 95% CI, 1.16–2.16). Associations in both directions were consistent across prespecified subgroups, with no significant effect modification. Conclusion: In adults with hypertension, sleep disturbance and AF were prospectively and reciprocally associated when evaluated longitudinally. These findings support a bidirectional relationship between sleep disturbance and AF and highlight the potential clinical relevance of assessing sleep health in patients with or at risk for AF.
- Open Access
Atrial Cardiomyopathy Refines Cardiovascular Mortality Risk Across Cardiometabolic Risk Factor Burden
Background: Electrocardiographic markers of atrial cardiomyopathy (AtCM) are associated with adverse cardiovascular outcomes. Whether AtCM further refines cardiovascular disease (CVD) mortality risk across increasing cardiometabolic risk factor (CMRF) burden is unclear. Methods: We analyzed 7,083 adults free of baseline CVD. AtCM was defined by the presence of ≥1 ECG marker: prolonged P-wave duration ≥120 ms in lead II, abnormal P-wave axis outside 0-75, or deep terminal negativity of the P wave in V1 <-100 μV. CMRF burden was defined as the presence of 0, 1, or ≥2 of hypertension, diabetes, and obesity. CVD mortality was ascertained through December 31, 2006. Results: Among 7,083 participants (mean age 58 years and 48% men), CVD mortality rates increased progressively across the six combined exposure groups. In a multivariable adjusted Cox proportional hazard analysis, AtCM identified higher-risk subgroups within each CMRF burden category, with risk increasing progressively across combined exposure groups and highest among participants with ≥2 risk factors and AtCM (HR 2.25, 95% CI 1.75-2.87). In secondary analyses, a similar pattern was observed for individual CMRFs, with the combination of AtCM and hypertension, diabetes, or obesity conferring the highest risk compared with participants with neither condition (HR (95% CI): 1.58 (1.31-1.89); 2.08 (1.62-2.68); and 1.47 (1.19-1.82), respectively). Conclusions: ECG-defined AtCM refined CVD mortality risk across increasing CMRF burden. Individuals with both AtCM and multiple CMRFs had the highest risk. These findings support the potential role of ECG-based AtCM assessment as a scalable approach to improve cardiovascular risk stratification among individuals with CMRFs.
Open AccessAtrial Cardiomyopathy Refines Cardiovascular Mortality Risk Across Cardiometabolic Risk Factor Burden
Background: Electrocardiographic markers of atrial cardiomyopathy (AtCM) are associated with adverse cardiovascular outcomes. Whether AtCM further refines cardiovascular disease (CVD) mortality risk across increasing cardiometabolic risk factor (CMRF) burden is unclear. Methods: We analyzed 7,083 adults free of baseline CVD. AtCM was defined by the presence of ≥1 ECG marker: prolonged P-wave duration ≥120 ms in lead II, abnormal P-wave axis outside 0-75, or deep terminal negativity of the P wave in V1 <-100 μV. CMRF burden was defined as the presence of 0, 1, or ≥2 of hypertension, diabetes, and obesity. CVD mortality was ascertained through December 31, 2006. Results: Among 7,083 participants (mean age 58 years and 48% men), CVD mortality rates increased progressively across the six combined exposure groups. In a multivariable adjusted Cox proportional hazard analysis, AtCM identified higher-risk subgroups within each CMRF burden category, with risk increasing progressively across combined exposure groups and highest among participants with ≥2 risk factors and AtCM (HR 2.25, 95% CI 1.75-2.87). In secondary analyses, a similar pattern was observed for individual CMRFs, with the combination of AtCM and hypertension, diabetes, or obesity conferring the highest risk compared with participants with neither condition (HR (95% CI): 1.58 (1.31-1.89); 2.08 (1.62-2.68); and 1.47 (1.19-1.82), respectively). Conclusions: ECG-defined AtCM refined CVD mortality risk across increasing CMRF burden. Individuals with both AtCM and multiple CMRFs had the highest risk. These findings support the potential role of ECG-based AtCM assessment as a scalable approach to improve cardiovascular risk stratification among individuals with CMRFs.
- Open Access
Blood Pressure Severity Modifies the Association Between Atrial Cardiopathy and Stroke Mortality
Background: Electrocardiographic (ECG) markers of atrial cardiopathy (AC) are associated with stroke mortality, but whether this association is modified by blood pressure (BP) is unknown. Methods: We analyzed 7,191 adults free of cardiovascular disease from the Third National Health and Nutrition Examination Survey who underwent baseline ECG. AC was defined by three ECG markers: prolonged P-wave duration (≥120 ms), abnormal P-wave axis (75°), and deep terminal negativity of the P wave in V1 (<−100 μV). AC burden (per additional AC marker) and AC presence (≥1 vs. 0 markers) were examined in relation to stroke mortality using Cox proportional hazards models. Participants were stratified by BP as normal/elevated (P =0.003). The HRs (95% CIs) per additional AC marker were 0.88 (0.52–1.49), 1.39 (1.03–1.88), and 2.94 (1.82–4.75) for normal/elevated BP, stage 1–2 hypertension, and severe hypertension, respectively. A similar pattern of associations was observed for AC presence, although the interaction with BP was not statistically significant. Conclusions: ECG-defined AC burden was independently associated with stroke mortality, with substantially stronger associations among individuals with severe hypertension, supporting BP as an important modifier of its prognostic significance.
Open AccessBlood Pressure Severity Modifies the Association Between Atrial Cardiopathy and Stroke Mortality
Background: Electrocardiographic (ECG) markers of atrial cardiopathy (AC) are associated with stroke mortality, but whether this association is modified by blood pressure (BP) is unknown. Methods: We analyzed 7,191 adults free of cardiovascular disease from the Third National Health and Nutrition Examination Survey who underwent baseline ECG. AC was defined by three ECG markers: prolonged P-wave duration (≥120 ms), abnormal P-wave axis (75°), and deep terminal negativity of the P wave in V1 (<−100 μV). AC burden (per additional AC marker) and AC presence (≥1 vs. 0 markers) were examined in relation to stroke mortality using Cox proportional hazards models. Participants were stratified by BP as normal/elevated (P =0.003). The HRs (95% CIs) per additional AC marker were 0.88 (0.52–1.49), 1.39 (1.03–1.88), and 2.94 (1.82–4.75) for normal/elevated BP, stage 1–2 hypertension, and severe hypertension, respectively. A similar pattern of associations was observed for AC presence, although the interaction with BP was not statistically significant. Conclusions: ECG-defined AC burden was independently associated with stroke mortality, with substantially stronger associations among individuals with severe hypertension, supporting BP as an important modifier of its prognostic significance.
- Open Access
- 5 May 2026
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 20 (4) , 430-436
Mitral annular calcification, coronary artery calcification, and risk of incident atrial fibrillation in the multi-ethnic study of atherosclerosis (MESA)
- 5 May 2026
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 20 (4) , 430-436
Open AccessMitral annular calcification, coronary artery calcification, and risk of incident atrial fibrillation in the multi-ethnic study of atherosclerosis (MESA)
- Open Access
Empiric Dietary Inflammatory Potential Score, Inflammatory Biomarkers, and Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
Background: Inflammation plays a key role in atrial fibrillation (AF) pathogenesis. The empirical dietary inflammatory potential (EDIP) score predicts circulating inflammatory biomarkers and adverse cardiac outcomes, but its association with incident AF is unclear. This study aimed to examine the relationship between EDIP score and AF risk. Methods: Participants from the Atherosclerosis Risk in Communities (ARIC) free of baseline AF who completed a validated food frequency questionnaire were included. Correlation of EDIP with inflammatory biomarkers (factor VIII, fibrinogen, von Willebrand factor, and C-reactive protein) was examined at baseline. Incident AF was ascertained using electrocardiograms, hospital records, and death certificates. Cox proportional hazards models estimated hazard ratios of AF across EDIP quantiles and per SD increase, adjusting for sociodemographic and cardiovascular risk factors. Results: Among 8,277 participants (54.1 years old, 51.3% women, 80% white), higher EDIP score correlated with circulating inflammatory biomarkers at baseline. Over a median 24.2 years of follow-up, 1,453 had incident AF (incident rate 8.6 per 1,000 person-years). Compared with the most anti-inflammatory diet (EDIP Q1), the most pro-inflammatory diet (EDIP Q5) was associated with increased AF risk (HR 1.21; 95% CI 1.03–1.43). Sex-stratified analyses showed a stronger association in men (HR 1.43; 95% CI 1.14–1.79), while no significant association was observed in women. Conclusions: Pro-inflammatory dietary patterns are independently associated with higher AF risk in a middle-aged cohort. These findings would support incorporating dietary inflammatory load into AF risk stratification. Clinical Perspective What Is New?: Higher Empirical Dietary Inflammatory Potential (EDIP) scores, indicating a more pro inflammatory diet, were associated with an increased long-term risk of atrial fibrillation (AF) in a large, biracial, community-based cohort followed for over two decades. Sex stratified analyses revealed a significant sex difference: higher EDIP scores were consistently associated with increased AF risk in men, whereas no significant association was observed in women, suggesting sex-specific susceptibility to EDIP. Obesity modified the association between EDIP and AF, with the strongest risk observed among individuals with BMI ≥30, while an inverse or attenuated association was seen among normal weight participants. What Are the Clinical Implications?: Dietary inflammatory load may serve as a meaningful and modifiable upstream AF risk factor, complementing conventional cardiovascular risk assessment, particularly in men and individuals with obesity. Incorporating dietary pattern assessment into routine AF risk stratification may help identify individuals who could benefit most from targeted lifestyle interventions. Public health and clinical prevention strategies promoting anti-inflammatory dietary patterns (e.g., increased intake of fruits, vegetables, and whole grains; reduced intake of processed meats and refined carbohydrates) could meaningfully reduce AF incidence. Recognition of sex specific differences in AF pathways reinforces the need for personalized preventive strategies, as diet inflammation mechanisms appear to influence AF development more prominently in men.
Open AccessEmpiric Dietary Inflammatory Potential Score, Inflammatory Biomarkers, and Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
Background: Inflammation plays a key role in atrial fibrillation (AF) pathogenesis. The empirical dietary inflammatory potential (EDIP) score predicts circulating inflammatory biomarkers and adverse cardiac outcomes, but its association with incident AF is unclear. This study aimed to examine the relationship between EDIP score and AF risk. Methods: Participants from the Atherosclerosis Risk in Communities (ARIC) free of baseline AF who completed a validated food frequency questionnaire were included. Correlation of EDIP with inflammatory biomarkers (factor VIII, fibrinogen, von Willebrand factor, and C-reactive protein) was examined at baseline. Incident AF was ascertained using electrocardiograms, hospital records, and death certificates. Cox proportional hazards models estimated hazard ratios of AF across EDIP quantiles and per SD increase, adjusting for sociodemographic and cardiovascular risk factors. Results: Among 8,277 participants (54.1 years old, 51.3% women, 80% white), higher EDIP score correlated with circulating inflammatory biomarkers at baseline. Over a median 24.2 years of follow-up, 1,453 had incident AF (incident rate 8.6 per 1,000 person-years). Compared with the most anti-inflammatory diet (EDIP Q1), the most pro-inflammatory diet (EDIP Q5) was associated with increased AF risk (HR 1.21; 95% CI 1.03–1.43). Sex-stratified analyses showed a stronger association in men (HR 1.43; 95% CI 1.14–1.79), while no significant association was observed in women. Conclusions: Pro-inflammatory dietary patterns are independently associated with higher AF risk in a middle-aged cohort. These findings would support incorporating dietary inflammatory load into AF risk stratification. Clinical Perspective What Is New?: Higher Empirical Dietary Inflammatory Potential (EDIP) scores, indicating a more pro inflammatory diet, were associated with an increased long-term risk of atrial fibrillation (AF) in a large, biracial, community-based cohort followed for over two decades. Sex stratified analyses revealed a significant sex difference: higher EDIP scores were consistently associated with increased AF risk in men, whereas no significant association was observed in women, suggesting sex-specific susceptibility to EDIP. Obesity modified the association between EDIP and AF, with the strongest risk observed among individuals with BMI ≥30, while an inverse or attenuated association was seen among normal weight participants. What Are the Clinical Implications?: Dietary inflammatory load may serve as a meaningful and modifiable upstream AF risk factor, complementing conventional cardiovascular risk assessment, particularly in men and individuals with obesity. Incorporating dietary pattern assessment into routine AF risk stratification may help identify individuals who could benefit most from targeted lifestyle interventions. Public health and clinical prevention strategies promoting anti-inflammatory dietary patterns (e.g., increased intake of fruits, vegetables, and whole grains; reduced intake of processed meats and refined carbohydrates) could meaningfully reduce AF incidence. Recognition of sex specific differences in AF pathways reinforces the need for personalized preventive strategies, as diet inflammation mechanisms appear to influence AF development more prominently in men.
- Open Access
- 15 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e040415
Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy
Background: High right ventricular pacing burden can result in pacing‐induced cardiomyopathy (PICM). The goal of this study was to investigate whether angiotensin‐converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and β‐blockers (BB) are associated with a reduction in risk of PICM in patients with high right ventricular pacing burden. Methods: This was a single‐center, retrospective study that included patients with normal ejection fraction and complete heart block who underwent pacemaker implantation. The medical therapy group included patients who received ACEI/ARB, BB, or both. The control group received neither ACEI/ARB nor BB. The primary end point was PICM, defined as upgrade to a biventricular device or reduction in ejection fraction to ≤40% without another cause identified. Fine‐Gray subdistribution hazard models were used to determine the relationship between medical therapy and cumulative incidence of PICM. Results: The study included 642 patients (mean±SD age, 71±14 years; 51% women). Over 10 years of follow‐up, 76 (11.8%) received ACEI/ARB only; 49 (7.6%) received BB only, and 86 (13.4%) received both. PICM occurred in 10 of 211 in the medical therapy group (4.7%) and in 30 of 431 in the control group (7.0%). In adjusted weighted analyses, the risk of PICM was significantly lower in the medical therapy group compared with the control group (hazard ratio [HR], 0.59 [95% CI, 0.45–0.77]). Patients on combination therapy had the lowest risk (HR, 0.46 [95% CI, 0.31–0.69]). Conclusions: Patients with high right ventricular pacing burden who received ACEI, ARB, or BB within 10 years of pacemaker implantation had a lower incidence of PICM.
- 15 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e040415
Open AccessEffect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy
Background: High right ventricular pacing burden can result in pacing‐induced cardiomyopathy (PICM). The goal of this study was to investigate whether angiotensin‐converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and β‐blockers (BB) are associated with a reduction in risk of PICM in patients with high right ventricular pacing burden. Methods: This was a single‐center, retrospective study that included patients with normal ejection fraction and complete heart block who underwent pacemaker implantation. The medical therapy group included patients who received ACEI/ARB, BB, or both. The control group received neither ACEI/ARB nor BB. The primary end point was PICM, defined as upgrade to a biventricular device or reduction in ejection fraction to ≤40% without another cause identified. Fine‐Gray subdistribution hazard models were used to determine the relationship between medical therapy and cumulative incidence of PICM. Results: The study included 642 patients (mean±SD age, 71±14 years; 51% women). Over 10 years of follow‐up, 76 (11.8%) received ACEI/ARB only; 49 (7.6%) received BB only, and 86 (13.4%) received both. PICM occurred in 10 of 211 in the medical therapy group (4.7%) and in 30 of 431 in the control group (7.0%). In adjusted weighted analyses, the risk of PICM was significantly lower in the medical therapy group compared with the control group (hazard ratio [HR], 0.59 [95% CI, 0.45–0.77]). Patients on combination therapy had the lowest risk (HR, 0.46 [95% CI, 0.31–0.69]). Conclusions: Patients with high right ventricular pacing burden who received ACEI, ARB, or BB within 10 years of pacemaker implantation had a lower incidence of PICM.
- Open Access
- 9 July 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (9) , 2226-2232
Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes
Background: The rapid evolution of cardiac implantable electronic devices (CIEDs) has increased remote transmission data, leading to excessive non‐actionable alerts (NAA) and alert fatigue.Objective: Optimize alert parameters to minimize NAA and evaluate the impact on clinical outcomes.Methods: We included 536 participants (mean age 75 (15) years, 60.4% male, 83.4% white) with CIEDs. In 413 patients, CIEDs were reprogrammed to censor alerts as follows: atrial fibrillation (AF) episodes < 5.5 h, persistent AF > 1 month with prior alerts, AF < 24 h on anticoagulation or with prior appendage occlusion, and non‐sustained ventricular tachycardia (NSVT) in defibrillator platforms. NAAs were tracked 90‐days pre‐ and post‐reprogramming. Incident ischemic stroke and sudden cardiac death (SCD) were assessed over a median 1.8‐year follow‐up. Logistic regression models examined associations between reprogramming and outcomes.Results: Reprogramming was implemented for AF alerts (69.5%, n = 287) and NSVT alerts (30.5%, n = 126). After reprogramming, NAAs significantly decreased from 6.68 (SD = 10.02) to 2.27 (SD = 4.58), p < 0.001. During follow‐up, ischemic stroke rates in AF patients were similar between reprogrammed (5.2%, n = 15) and control groups (5.4%, n = 5). In those with NSVT alerts, SCD incidence was lower in reprogrammed (2.3%, n = 3) versus controls (9.3%, n = 3). In logistic regression models adjusted for demographics, CHA₂DS₂VASC score, anticoagulation status, and prior stroke history, there was no statistically significant difference in stroke risk between groups (OR 0.82 [0.27–2.51]).Conclusions: Guideline‐based alert parameters in CIED patients significantly reduced NAA burden with no increasing in adverse outcomes in patients with device‐detected AF or NSVT alerts. This approach may reduce noise and safely improve efficiency.
- 9 July 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (9) , 2226-2232
Open AccessExploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes
Background: The rapid evolution of cardiac implantable electronic devices (CIEDs) has increased remote transmission data, leading to excessive non‐actionable alerts (NAA) and alert fatigue.Objective: Optimize alert parameters to minimize NAA and evaluate the impact on clinical outcomes.Methods: We included 536 participants (mean age 75 (15) years, 60.4% male, 83.4% white) with CIEDs. In 413 patients, CIEDs were reprogrammed to censor alerts as follows: atrial fibrillation (AF) episodes < 5.5 h, persistent AF > 1 month with prior alerts, AF < 24 h on anticoagulation or with prior appendage occlusion, and non‐sustained ventricular tachycardia (NSVT) in defibrillator platforms. NAAs were tracked 90‐days pre‐ and post‐reprogramming. Incident ischemic stroke and sudden cardiac death (SCD) were assessed over a median 1.8‐year follow‐up. Logistic regression models examined associations between reprogramming and outcomes.Results: Reprogramming was implemented for AF alerts (69.5%, n = 287) and NSVT alerts (30.5%, n = 126). After reprogramming, NAAs significantly decreased from 6.68 (SD = 10.02) to 2.27 (SD = 4.58), p < 0.001. During follow‐up, ischemic stroke rates in AF patients were similar between reprogrammed (5.2%, n = 15) and control groups (5.4%, n = 5). In those with NSVT alerts, SCD incidence was lower in reprogrammed (2.3%, n = 3) versus controls (9.3%, n = 3). In logistic regression models adjusted for demographics, CHA₂DS₂VASC score, anticoagulation status, and prior stroke history, there was no statistically significant difference in stroke risk between groups (OR 0.82 [0.27–2.51]).Conclusions: Guideline‐based alert parameters in CIED patients significantly reduced NAA burden with no increasing in adverse outcomes in patients with device‐detected AF or NSVT alerts. This approach may reduce noise and safely improve efficiency.
- 15 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (15) , 1051-1059
Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized Trial
BACKGROUND: Catheter ablation of ventricular arrhythmias, one of the most rapidly growing procedures in cardiac electrophysiology, is associated with magnetic resonance imaging–detected brain lesions in more than half of cases. Although a retrograde aortic approach is conventional, modern tools enable entry through a transseptal approach that may avoid embolization of debris from the arterial system. We sought to test the hypothesis that a transseptal puncture would mitigate brain injury compared with a retrograde aortic approach. METHODS: The TRAVERSE trial (Transseptal Versus Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli) was a multicenter randomized controlled comparative effectiveness trial. Patients with left ventricular arrhythmias undergoing catheter ablation procedures were randomly assigned to a transseptal puncture approach compared (1:1) with a retrograde aortic approach. The primary outcome was the presence of an acute brain lesion detected by magnetic resonance imaging. Secondary outcomes included clinically manifest complications, procedural efficacy, and 6-month neurocognitive assessments. RESULTS: Among the 62 patients randomly assigned to a retrograde aortic approach with postoperative brain magnetic resonance imaging, 28 (45%) exhibited an acute brain lesion compared with 19 of the 69 (28%) of those randomized to a transseptal puncture ( P =0.036). No differences in clinically manifest complications or procedural efficacy were observed. More patients in the retrograde aortic arm were categorized as having a high likelihood of cognitive impairment at 6 months (33% compared with 19% of those in the transseptal arm), but substantial loss to follow-up was present. CONCLUSIONS: Among patients undergoing left ventricular catheter ablation procedures, a transseptal approach reduced the risk of acute brain lesions by nearly half compared with a retrograde aortic approach without sacrificing safety or efficacy. Given a likely embolic pathogenesis, the brain magnetic resonance imaging findings may reflect a propensity to other organ damage; these findings may extend to other procedures requiring left ventricular entry. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03946072.
- 15 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (15) , 1051-1059
Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized Trial
BACKGROUND: Catheter ablation of ventricular arrhythmias, one of the most rapidly growing procedures in cardiac electrophysiology, is associated with magnetic resonance imaging–detected brain lesions in more than half of cases. Although a retrograde aortic approach is conventional, modern tools enable entry through a transseptal approach that may avoid embolization of debris from the arterial system. We sought to test the hypothesis that a transseptal puncture would mitigate brain injury compared with a retrograde aortic approach. METHODS: The TRAVERSE trial (Transseptal Versus Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli) was a multicenter randomized controlled comparative effectiveness trial. Patients with left ventricular arrhythmias undergoing catheter ablation procedures were randomly assigned to a transseptal puncture approach compared (1:1) with a retrograde aortic approach. The primary outcome was the presence of an acute brain lesion detected by magnetic resonance imaging. Secondary outcomes included clinically manifest complications, procedural efficacy, and 6-month neurocognitive assessments. RESULTS: Among the 62 patients randomly assigned to a retrograde aortic approach with postoperative brain magnetic resonance imaging, 28 (45%) exhibited an acute brain lesion compared with 19 of the 69 (28%) of those randomized to a transseptal puncture ( P =0.036). No differences in clinically manifest complications or procedural efficacy were observed. More patients in the retrograde aortic arm were categorized as having a high likelihood of cognitive impairment at 6 months (33% compared with 19% of those in the transseptal arm), but substantial loss to follow-up was present. CONCLUSIONS: Among patients undergoing left ventricular catheter ablation procedures, a transseptal approach reduced the risk of acute brain lesions by nearly half compared with a retrograde aortic approach without sacrificing safety or efficacy. Given a likely embolic pathogenesis, the brain magnetic resonance imaging findings may reflect a propensity to other organ damage; these findings may extend to other procedures requiring left ventricular entry. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03946072.
- Open Access
- 6 April 2025
- Published by Elsevier in Structural Heart
- Vol. 9 (8) , 100469
Postoperative Transesophageal Echocardiographic Evaluation of Surgical Left Atrial Appendage Exclusion: Characterization and Predictors of Success
- 6 April 2025
- Published by Elsevier in Structural Heart
- Vol. 9 (8) , 100469
Open AccessPostoperative Transesophageal Echocardiographic Evaluation of Surgical Left Atrial Appendage Exclusion: Characterization and Predictors of Success
- Open Access
- 18 March 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-7
Clinical management after surgical left atrial appendage exclusion
Surgical left atrial appendage (LAA) closure is an increasingly utilized approach to mitigate the risk of cardioembolic stroke in patients with atrial fibrillation (AF). Consensus is lacking regarding optimal stroke prevention management after surgical LAA management. To elucidate real world clinical management of anticoagulation in patients undergoing surgical LAA management. Over a 7-year period at a single center, 458 participants carried a diagnosis of AF and underwent surgical exclusion of their LAA during concomitant cardiac surgery. Follow-up was catalogued via retrospective chart review; median follow-up was 2 years. Successful LAA ligation was defined as maximal stump depth < 1.0 cm by transesophageal echocardiography (TEE) without distal leak. Among 458 patients, 299 were discharged on OAC (142 DOAC and 157 warfarin). Of these, 31% (94/299) had a follow-up TEE. Among those without a TEE, 32% (65/205) were taken off OAC; among those who underwent TEE, 59% (55/94) were taken off OAC. Using a logistic regression model, there was no relationship between age, sex, CHA2DS2-VASc score, or creatinine and the probability of coming off of OAC. Among the 94 patients discharged on OAC who had a follow-up TEE:10 were unable to assess adequacy of closure, 69 were successful, and 15 showed unsuccessful closure. In the group with imaging confirmed successful exclusion of their LAA, 67% (46/69) were taken off their oral anticoagulation, with cessation occurring after the TEE in 93% (43/46) of those patients. Clinical management after surgical LAA management, particularly with regard to LAA imaging and OAC continuation, is highly heterogeneous.
- 18 March 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-7
Open AccessClinical management after surgical left atrial appendage exclusion
Surgical left atrial appendage (LAA) closure is an increasingly utilized approach to mitigate the risk of cardioembolic stroke in patients with atrial fibrillation (AF). Consensus is lacking regarding optimal stroke prevention management after surgical LAA management. To elucidate real world clinical management of anticoagulation in patients undergoing surgical LAA management. Over a 7-year period at a single center, 458 participants carried a diagnosis of AF and underwent surgical exclusion of their LAA during concomitant cardiac surgery. Follow-up was catalogued via retrospective chart review; median follow-up was 2 years. Successful LAA ligation was defined as maximal stump depth < 1.0 cm by transesophageal echocardiography (TEE) without distal leak. Among 458 patients, 299 were discharged on OAC (142 DOAC and 157 warfarin). Of these, 31% (94/299) had a follow-up TEE. Among those without a TEE, 32% (65/205) were taken off OAC; among those who underwent TEE, 59% (55/94) were taken off OAC. Using a logistic regression model, there was no relationship between age, sex, CHA2DS2-VASc score, or creatinine and the probability of coming off of OAC. Among the 94 patients discharged on OAC who had a follow-up TEE:10 were unable to assess adequacy of closure, 69 were successful, and 15 showed unsuccessful closure. In the group with imaging confirmed successful exclusion of their LAA, 67% (46/69) were taken off their oral anticoagulation, with cessation occurring after the TEE in 93% (43/46) of those patients. Clinical management after surgical LAA management, particularly with regard to LAA imaging and OAC continuation, is highly heterogeneous.